NEW YORK, Aug. 25, 2016 /PRNewswire/ -- While there are many positive factors driving the in vitro diagnostics market, according to Kalorama Information, marketers will want to be keep their eye on certain challenges as well. Overcoming them could be a key to revenue growth, says the market research firm with an specialty in IVD. The finding was made in Kalorama Information's latest report, The Worldwide Market for In Vitro Diagnostic Tests, 10th Edition.
Though the IVD market is expected to be boosted by new innovations and an increased recognition of personalized medicine techniques, there's a catch-up period that testmakers will hit between the innovation and acceptance.
"The commercialization of sophisticated new IVD products and technologies comes as a double edged sword," said Shara Rosen, author of the report. "Many of these new devices and technologies are expected to carry a high price tag and the payment infrastructure in most countries has not evolved to cover many of the newer approaches to patient management."
The result, the report said as is often the case, is that technology is far ahead of healthcare regulations and reimbursement plans. The onus is therefore on manufacturers to prove their new intervention is not only effective but also supplies a cost effective treatment alternative. They cannot assume manufacturers will be delighted with each new innovation. Proof, proof and more proof, the report says, is the way to a successful test product.
The report also said that the increasing cost of providing healthcare services to an aging population, a rise in admissions and a trend to reduce length of stay are shifting the focus of care from the hospital to the home. But the home setting is not a natural one for test companies used to selling products to be used in hospitals are clinics. However, few studies to evaluate the cost effectiveness of home telemedicine have been published and payment schedules for home care are still in the planning stages. Liability issues are also a concern with products used outside of the hospital or clinic.
Slow European growth in recent years is also troubling. As the report finds that an essentially flat IVD market in Europe expected for the next few years. This is a challenge, as the report finds that the European IVD market is one-quarter of the entire world opportunity. Maximizing emerging market sales will be an important strategy for IVD companies to counter the flatness of a such a significant market, but they will face competition in these markets as well.
The report, The Worldwide Market for In Vitro Diagnostic Tests, is a comprehensive look at the IVD industry and all of its segments. The report has detailed market estimates of clinical chemistry, molecular, microbiology and tissue diagnostic markets, as well as others. The report is global in scope and can be found at: http://www.kaloramainformation.com/Worldwide-Vitro-Diagnostic-10206771/.
Please link any media or news references to our reports or data to http://www.kaloramainformation.com/.
About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on www.marketresearch.com and www.profound.com.
We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog at www.kaloramainformation.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kalorama-three-trends-that-should-worry-ivd-companies-300317698.html
SOURCE Kalorama Information